Hela Kallel
CMC Technology lead CEPI
Experienced vaccine and mRNA technology professional with a strong scientific background in vaccine development and enabling manufacturing technologies. Currently working at CEPI, with a focus on advancing innovative mRNA platforms and supporting their progression from early development to proof of concept. Demonstrated expertise in evaluating emerging technologies, managing complex R&D projects, and collaborating with diverse global partners, including industry, academic institutions, and Global South manufacturers.
Seminars
Wednesday 22nd July 2026
Advancements in Innovative mRNA Manufacturing Technologies Development for Epidemic, Pandemic Preparedness & Equitable Access
1:30 pm
- Continuous mRNA manufacturing to reduce the CoGs and enable global access
- Accelerating mRNA vaccine manufacturing through the development of synthetic DNA template production and rapid analytics
- Improving mRNA thermostability by using different technologies, including microarrays and spray-drying
